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Phospholemman (FXYD1) is a homolog of the Na,K-ATPase  subunit (FXYD2), a small accessory protein that modulates ATPase
activity. Here we show that phospholemman is highly expressed in selected structures in the CNS. It is most abundant in cerebellum,
where it was detected in the molecular layer, in Purkinje neurons, and in axons traversing the granule cell layer. Phospholemman was
particularly enriched in choroid plexus, the organ that secretes CSF in the ventricles, where it colocalized with Na,K-ATPase in the apical
membrane. It was also enriched, with Na,K-ATPase, in certain tanycytes or ependymal cells of the ventricle wall. Two different experi-
mental approaches demonstrated that phospholemman physically associated with the Na,K-ATPase in cerebellum and choroid plexus:
the proteins copurified after detergent treatment and co-immunoprecipitated from solubilized crude membranes using either anti-
phospholemman or anti-Na,K-ATPase antibodies. Phospholemman antibodies precipitated all three Na,K-ATPase  subunit isoforms
(1–3) from cerebellum, indicating that the interaction is not specific to a particular  isoform and consistent with the presence of
phospholemman in both neurons and glia. Antibodies against the C-terminal domain of phospholemman reduced Na,K-ATPase activity
in vitro without effect on Na affinity. At least two other FXYD family members have been detected in the CNS, suggesting that additional
complexity of sodium pump regulation will be found.
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Introduction
Phospholemman was first discovered as a readily phosphorylated
protein in sarcolemma preparations from cardiac and skeletal
muscle (Walaas et al., 1977; Jones et al., 1979). It is a 72-amino
acid membrane-spanning protein with a 20-amino acid cleavable
signal sequence (Palmer et al., 1991). It is phosphorylated by
protein kinases A and C in the heart in response to - and
-adrenergic stimulation and in response to insulin in skeletal
muscle (Presti et al., 1985a,b; Walaas et al., 1988, 1994). It is also
a target of myotonic dystrophy and NIMA (Never in mitosis,
gene A) kinases (Lu et al., 1994; Mounsey et al., 1999, 2000). This
suggests that phospholemman has a role in signal transduction to
integrate converging regulatory pathways. The link between
phospholemman phosphorylation and its physiological role is
not yet understood, however. Phospholemman induces ion and
taurine permeability in oocytes and lipid bilayers (Moorman et
al., 1992; Mounsey et al., 2000), but evidence is presented here
that it is an accessory protein of Na,K-ATPase.
Phospholemman and the  subunit of the Na,K-ATPase are
members of the FXYD gene family, which has seven members in
mammals (Sweadner and Rael, 2000). Several FXYD proteins, the
 subunit (FXYD2), PLMS (a dogfish shark FXYD family mem-
ber), CHIF (FXYD4), and FXYD7, have been shown to associate
with Na,K-ATPase (Mahmmoud et al., 2000; Therien and
Blostein, 2000; Beguin et al., 2001, 2002), and while this manu-
script was being revised, Crambert et al. (2002) independently
showed that phospholemman interacts with Na,K-ATPase when
expressed in Xenopus oocytes and in cardiac and skeletal muscle
sarcolemma. The greatest sequence homology in the gene family
is in a stretch of 35 amino acids that includes the transmembrane
span, a portion of the intracellular domain, and a portion of the
extracellular domain with the FXYD motif (PFxYD or Pro-Phe-
x-Tyr-Asp) that identifies the family. Mutations in the PFxYD
motif of  and CHIF were shown to disrupt interaction with the
Na,K-ATPase (Beguin et al., 2001). When the FXYD family trans-
membrane span amino acid sequences are displayed on a helical
wheel, they have invariant and nearly invariant residues all clus-
tered on one face, with small and bulky residues aligned sepa-
rately to form a ridge-and-groove structure (Sweadner and Rael,
2000). This is consistent with right-handed helix packing and
suggests similar specificity in protein–protein interaction in the
membrane, such as by interacting with the same site on
Na,K-ATPase.
Phospholemman mRNA expression has been detected in the
CNS (Chen et al., 1997; Bres et al., 2000; Bogaev et al., 2001), and
phospholemman protein has been detected in cerebellar astro-
cytes cultured from 8-d-old rats (Moran et al., 2001). We set out
to determine the distribution of phospholemman in the CNS and
to test the hypothesis that it forms a complex with Na,K-ATPase.
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Parts of this paper were published previously in abstract form
(Sweadner et al., 2001).
Materials and Methods
Immunofluorescence microscopy. Adult outbred rats were used for immu-
nofluorescence microscopy. The methods for fixation, tissue sectioning,
and double-label immunofluorescence have been described in detail
elsewhere (Wetzel and Sweadner, 2001). The antibody used to detect
phospholemman was an affinity-purified polyclonal rabbit antibody
against the C terminus (now called PLM-C1; Moorman et al., 1992). This
antibody also appropriately stains the sarcolemma of cardiac and skeletal
muscle (results not shown). To detect Na,K-ATPase isoforms, we used
monoclonal antibodies specific for rat Na,K-ATPase 1 subunit (McK1;
Arystarkhova and Sweadner, 1996) and for 2 (McB2; Pacholczyk and
Sweadner, 1997). A monoclonal antibody specific for 3 (XVI-F9G10;
MA-319; Affinity BioReagents) was also used to stain cerebellum in ex-
periments not shown. Confocal microscopy was performed with a Nikon
(Melville, NY) TE300 fluorescence microscope equipped with a Bio-Rad
(Hercules, CA) MRC 1024 scanning laser confocal system.
Membrane preparation and Na,K-ATPase purification. Similar proce-
dures for membrane preparation were used for both cerebellum and
choroid plexus. First, a crude microsome preparation was made by dif-
ferential centrifugation. Tissue (bovine in most experiments) was ho-
mogenized in 0.315 M sucrose, 20 mM TrisCl, and 1 mM EDTA, pH 7.4
(SET), for cerebellum or (in mM): 250 sucrose, 30 imidazole, and 1
EDTA, pH 7.3, for choroid plexus. Centrifugation was for 15 min at
5800 g; pellets were collected, rehomogenized, and pelleted again; and
the supernatants were combined and centrifuged for 1 hr at 140,000 g.
The final pellets were collected and resuspended in SET. These fractions
were used for immunoprecipitation experiments.
For partial purification of the Na,K-ATPase, the SDS-extraction pro-
cedure was used (Jørgensen, 1988). Bovine choroid plexus microsomes
were suspended at 1.4 mg/ml in buffer containing (in mM): 2 ATP, 30
histidine, and 2 EDTA, pH 7.4, and SDS was added slowly with stirring
from a stock solution to a final concentration of 0.56 mg/ml. The mixture
was allowed to stir for 30 min at room temperature and then loaded onto
36 ml 7–30% sucrose gradients in (in mM): 20 Tris-Cl and 1 EDTA, pH
7.4. The gradients were centrifuged for 6 hr at 27,000 rpm in a Sorvall 627
swinging bucket rotor. Fractions were collected from a puncture at the
bottom of the tube, diluted, and concentrated by centrifugation at
140,000 g for 30 min. Canine or rat brain and choroid plexus tissue was
used in some experiments with equivalent results.
Canine cardiac sarcolemma, used as a Western blot-positive control,
was isolated as previously described (Jones, 1988). Rat kidney (renal
medulla) Na,K-ATPase used as a control in activity measurements was
purified by the Jørgensen SDS-extraction procedure above.
Immunoblot. SDS-gel electrophoresis was on Tricine gels made with
12.5% polyacrylamide (Schagger and von Jagow, 1987). To detect Na,K-
ATPase  subunits in blots of bovine tissue, anti-KETYY (a gift from Dr.
J. Kyte, University of California, San Diego, CA) was used as a pan-
specific probe that detects the 1–3 isoforms equally well. To detect
each isoform individually, monoclonal antibody 6F was used for1 (De-
velopmental Studies Hybridoma Bank); McB2 was used for2; and XVI-
F9G10 was used for 3 (described above). In Figure 5, the  subunit was
stained with K1, a rabbit antiserum against rat 1 cut from a gel (Swead-
ner and Gilkeson, 1985), and in Figure 6,5, a monoclonal antibody that
reacts with all three isoforms, was also used for either immunoprecipita-
tion or staining of blots (Developmental Studies Hybridoma Bank).
Affinity-purified antibodies against the C terminus of phospholemman,
PLM-C1 (described above), or the extracellular portion, monoclonal
antibody PLM-B8 (Moorman et al., 1995), were used to detect
phospholemman.
Immunoprecipitation. To immunoprecipitate the Na,K-ATPase sub-
unit, we used either monoclonal antibody 6H (a gift from Dr. M. J.
Caplan, Yale University Medical School, New Haven, CT) or monoclonal
antibody 5 (described above). To immunoprecipitate phospholem-
man, the antibodies against either the N terminus (mouse monoclonal
PLM-B8) or the C terminus (PLM-C1) were used (described above).
Membranes from either choroid plexus or cerebellum (bovine) at 2 mg of
protein/ml were solubilized with 6 mg/ml n-dodecyl octaethylene glycol
monoether detergent (C12E8; Calbiochem, La Jolla, CA) for 10 min at
room temperature in a buffer containing (in mM): 140 NaCl, 25 imida-
zole, and 1 EDTA, pH 7.3. The extract was diluted with an equal volume
of detergent-free buffer, and insoluble material was sedimented by cen-
trifugation for 30 min at 20,000  g at 4°C. The pellet was checked for
residual Na,K-ATPase, which was very low. The supernatant was incu-
bated with primary antibodies or control IgG (1–2 g/ml) overnight at
4°C with rocking. The immune complexes were collected after 2 hr of
incubation with 40 l of secondary goat anti-rabbit or goat anti-mouse
IgG antibodies covalently bound to agarose beads (Sigma, St. Louis,
MO). Immunoprecipitates were collected by centrifugation at 9300 g
for 10 min at 4°C and washed four times with solubilization buffer con-
taining 0.05% C12E8. After the final wash, the pellet was resuspended in
40l of 1 electrophoresis sample buffer. Samples were incubated for 20
min at room temperature and centrifuged at 9300 g for 10 min. Super-
natants were saved. Pellets were washed with an additional 20 l of
electrophoresis sample buffer and centrifuged again. The supernatants
were combined and heated for 10 min at 65°C to dissociate IgG before
loading on the gel. The excess IgG heavy and light chains, a trace of
undissociated IgG dimer, and some other contaminants originating in
the antibody can be detected in the blots in Figures 6 A and 7.
Epitopes recognized by the PLM-C1 and PLM-B8 antibodies were
mapped using cellulose-bound PepSpots (Jerini Bio Tools) by methods
described previously (Kobayashi and Jones, 1999). The PepSpots sheet
contained a series of immobilized 13 mer synthetic peptides, each over-
lapping by 11 residues, that covered the primary structure of canine
phospholemman. PLM-C1, which was raised against a peptide with the
sequence GTFRSSIRRLSTRRR, required the sequence FRSSIRRL for
binding. PLM-B8, which is a monoclonal antibody raised against recom-
binant phospholemman expressed in Sf21 insect cells (Chen et al., 1998),
required the N-terminal sequence EHDPFTYDY for binding. Although
this epitope contains the conserved FXYD motif, the antibody is quite
specific. PLM-B8 does not recognize rat phospholemman, which differs
only by a P for H substitution in the epitope and two amino acids (HT
substituting for QS) immediately after it. We also did not see cross-
reactivity of PLM-B8 with the homologous sequence in FXYD2 (TEN-
PFEYDY; results not shown).
Antibody-induced changes in Na,K-ATPase activity. SDS-purified bo-
vine choroid plexus Na,K-ATPase was used to measure the effects of
incubation with anti-phospholemman antibodies. The specific activity of
the preparation (ouabain-sensitive ATPase activity) was 85mol of ATP
hydrolyzed  hr1  mg of protein1, measured in (in mM): 130 NaCl, 20
KCl, 1 ATP, 1 EDTA, 5 EGTA, 4 MgCl2, and 30 Tris-HCl, pH 7.4. To
assess the effect of antibodies on activity, the same medium was used but
with either 5 or 100 mM NaCl. The hydrolysis of ATP was measured at
37°C by a colorimetric assay, and assays were performed with and with-
out 2 mM ouabain. The antibodies used were PLM-C2, a newer rabbit
antiserum that is equivalent to PLM-C1 (a gift from Dr. J. Cheung,
Geisinger Medical Center; Song et al., 2002), PLM-B8 (described above),
or control rabbit or mouse IgG as appropriate (Sigma). Before use, all
antibodies were diluted with 4 –5 volumes of (in mM): 50 NaCl and 20
Tris-HCl, pH 7.5, concentrated with a centrifugal filter (Amicon, Bev-
erly, MA; 30 kDa cutoff), and washed three times with three volumes of
the same buffer. This procedure controlled NaCl concentration and re-
moved any phosphate buffer that would interfere with the assay, as well
as Tris and glycine present in the affinity-purified antibody stock. Anti-
body protein was added in a 10fold excess over sample protein.
For Na affinity measurements with PLM-C2 antibodies or control
IgG, the assay buffer contained the same basic constituents as the normal
assay medium with 20 mM K and different concentrations of Na from
2.2 to 80 mM. The ionic strength was kept constant by addition of choline
Cl such that [Na] [K] [choline] 168 mM. ATP hydrolysis was
measured with [- 32P]ATP. Preincubation with antibodies was for 4 hr
at 4°C in (in mM): 44 NaCl and 17 Tris-HCl, pH 7.5. This relatively low
NaCl buffer was used because of the need to minimize the amount of
NaCl added to the assay mixture during Na affinity measurements. The
final concentration of Na contributed by the addition of enzyme pre-
incubated with antibody or control IgG was 0.23 mM.
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Results
Figure 1 shows the aligned sequences of human phospholemman
and Na,K-ATPase  subunit. For the portion extending from the
end of the signal sequence of phospholemman to the end of the 
sequence, the identity is 51%, and the similarity is 64%. For
mouse, the identity is 48%, and the similarity is 64%, and for rat,
the identity is 41%, and the similarity is 61% (data not shown).
The circles represent residues that are highly conserved in the
entire FXYD family, and the dots represent additional residues
that are identical between phospholemman and . This strong
similarity led to the hypothesis that phospholemman associates
with Na,K-ATPase.
Phospholemman expression in brain
Figure 2 shows the distribution of phospholemman immunore-
activity in the rat CNS. This montage of images from a rat brain
sagittal section shows abundant immunoreactivity in the molec-
ular layer of the cerebellum and in the choroid plexus in the
lateral, third, and fourth ventricles. In addition, bright immuno-
reactivity was seen in cells of a portion of the ependymal lining of
the lateral ventricle on its rostral surface posterior to the caudate
putamen. Other areas showed much less immunoreactivity, al-
though a detailed examination of all brain areas has not been
performed.
Higher-magnification images of the cerebellar cortex double-
labeled for the 1 subunit isoform of Na,K-ATPase and phos-
pholemman are shown in Figure 3A–C and double-labeled for2
and phospholemman in Figure 3D–F. Immunoreactivity for 1,
2, and 3 (results not shown) and phospholemman in the mo-
lecular layer was diffuse or fine-grained and was absent from the
cytoplasm of the major Purkinje cell somas and dendrites, as
expected for a membrane protein. Purkinje cell somas were com-
pletely unstained for 1 but exhibited surface ring staining for
phospholemman. Purkinje cell somas were also usually un-
stained for 2 but were often in close contact with 2-stained
astrocytes. The basket cell processes under the Purkinje cells were
not visible with immunoreactivity for1 or2, but we confirmed
that they are phospholemman-negative in other experiments us-
ing a double label with antibody to3, which stains the basket cell
processes well (results not shown) (for 3 distribution, see
McGrail et al., 1991; Peng et al., 1997). In the granule cell layer,
the only prominent immunoreactivity for phospholemman was
in axons passing through. The  antibodies visualized other cell
types in the granular layer; immunoreactivity for 1 highlighted
the glomeruli (brightest), and each granule cell was ring-stained.
The antibody to 2 stained the astrocytes, which send irregular
processes between and around the granule cells. Phospholem-
man immunoreactivity with granule cells and glomeruli was be-
low the level of detection, and the stain for granular layer astro-
cytes was very light. With this distribution, the most likely cells
producing high levels of phospholemman in the cerebellum were
the Purkinje neurons, the Bergmann glia (which are the special-
ized astrocytes of the molecular layer), or both. No other cell type
has this distribution of arborization.
The choroid plexus is a simple cuboidal epithelium of polar-
ized cells, and the Na,K-ATPase is located on the apical mem-
brane, where its net outward transport of Na drives the secre-
tion of CSF (Wright, 1978). Figure 3G–I shows that
phospholemman colocalized with the 1 subunit of the Na,K-
ATPase in the apical membrane. Similar colocalization of Na,K-
ATPase and phospholemman was seen in bovine choroid plexus
(results not shown). Figure 3G–I also shows strong immunore-
activity for Na,K-ATPase and phospholemman in the apical
membrane of some of the cells lining the ventricular wall. The
distribution of Na,K-ATPase to the apical membrane predicts
that these cells, like choroid plexus itself, may have a secretory
function. On the basis of position, morphology, and apical spe-
cializations, it seems likely that these cells are tanycytes (Bruni,
1998).
The fact that phospholemman immunoreactivity in the cere-
bellar molecular layer appears to be brighter than 1 or 2 im-
munoreactivity is not evidence that there is an excess of phos-
pholemman for several reasons: only one  isoform at a time was
stained; the exposure intensity for the  subunits was adjusted to
avoid overexposing the structures stained in the granular layer;
and comparison of immunoreactivity of two antibodies is in any
Figure 1. Alignment of phospholemman and the subunit. The sequences of human phospholemman anda are compared to display their similarity. One gap was allowed in phospholemman
to allow alignment of three identical amino acids in the N-terminal region. The leader sequence of phospholemman and the alternatively spliced N terminus of  are underlined and italicized.
Following these two structures, the homology begins. As shown previously (Sweadner and Rael, 2000), there is a set of highly conserved amino acids that characterizes the entire FXYD family; these
are marked with circles. Lines mark additional residues that are identical between phospholemman and. The known phosphorylation sites in the phospholemman C terminus are indicated; this
segment has no counterpart in.
Figure 2. Phospholemman immunoreactivity in adult rat brain. A section of rat brain (with-
out the olfactory bulb) stained with antibody against the C-terminal end of phospholemman,
PLM-C1, is shown. The brightest immunoreactivity was in the cerebellar molecular layer (ml )
and in the choroid plexus (CP), whereas the cerebellar granular layer ( gl ) was almost un-
stained. Stained choroid plexus in (left to right) lateral, third, and fourth ventricles can be seen,
as well as in presumptive tanycytes of the ependyma of the lateral ventricle (asterisk). Occa-
sional folds in the section produced irregular brighter lines. The image is a montage of many
individual confocal images.
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event not quantitative. The difference in the proportion of im-
munoreactivity for  and phospholemman between molecular
and granular layers, however, does imply that there is much less
phospholemman in the granular layer relative to  subunits. Fig-
ure 4 shows that this was reflected in the ratio of phospholemman
to  assessed with immunoblots. Bovine tissue was used instead
of rat here because of the ease and yield of dissection. To detect all
Na,K-ATPase  isoforms equally, an antibody against a shared
determinant at the C terminus, KETYY, was used. Two different
anti-phospholemman antibodies, against the N- and C-terminal
ends of the protein, gave the same result. The ratio of phos-
pholemman to  was much higher in membrane fractions iso-
lated from choroid plexus than in membrane from whole cere-
bellar cortex and was if anything higher than the ratio seen in the
cardiac sarcolemma fraction used as a control.
Copurification of phospholemman with Na,K-ATPase
The Na,K-ATPase can be purified from highly active tissue
sources by a relatively simple technique that exploits its unusual
resistance to denaturation by the strong detergent SDS (Jør-
gensen, 1988; Sweadner, 1988). In the presence of ATP or ADP to
stabilize the enzyme at the active site, SDS (at ratios of up to 0.4
mg/mg of protein) extracts contaminating proteins and leaves
the Na,K-ATPase in the lipid bilayer. The membranes are sepa-
rated from the extracted proteins and from free SDS by sedimen-
tation on sucrose gradients. The  subunit of the kidney copuri-
fies with Na,K-ATPase  and  subunits by this method;
therefore, it was tried with phospholemman-containing mem-
branes from choroid plexus and brain. Figure 5 illustrates the
result with bovine choroid plexus. Essentially all of the phos-
pholemman cosedimented with the Na,K-ATPase in the gradi-
ent, with a peak at18% sucrose, as shown by blots of gradient
fractions stained for  and phospholemman. No free phos-
pholemman fraction was detected. The same copurification of
phospholemman with the Na,K-ATPase, without a free phos-
pholemman fraction, was obtained with canine choroid plexus
and with microsomes from whole rat brain (data not shown).
Coimmunoprecipitation of phospholemman
with Na,K-ATPase
To determine whether phospholemman and Na,K-ATPase form
a stable complex, immunoprecipitation was performed with
C12E8 detergent-solubilized crude membranes obtained from ei-
Figure 3. Phospholemman immunoreactivity in cerebellar cortex, choroid plexus, and ven-
tricular wall. A–C, Cerebellar cortex double-labeled for phospholemman ( green), the1 sub-
unit of Na,K-ATPase (red), and the combined images. ml, Molecular layer; gl, granular layer.
Immunoreactivity for1 in the glomeruli ( g) in the granular layer was particularly bright and
the granule cell bodies ( gc) were also stained, as was the molecular layer. Antibody to phos-
pholemman stained the molecular layer and ring-stained Purkinje cells ( pc) and axons in the
granular layer. D–F, Same structures double-labeled for the2 isoform (red) and phospholem-
man ( green). Purkinje cells occasionally stained for 2, as reported previously (Peng et al.,
1997); astrocytes in the granular layer (astr) were stained prominently for2 but very lightly for
phospholemman. G–I, Section of rat brain more lateral than that of Figure 2 double-labeled for
Na,K-ATPase1 (red) and phospholemman ( green). Both proteins were confined to the apical
surface of the polarized epithelium of the choroid plexus (CP), which lies here in a narrow
ventricular space ventral to the chamber seen in Figure 2. On the rostral surface of the ventricle,
a cuboidal epithelium of ependymal cells, presumed tanycytes (e), is seen that was prominently
stained for both Na,K-ATPase and phospholemman at its apical surface.
Figure 4. Ratio of phospholemman to Na,K-ATPase. Although the true ratio of phospholem-
man to the Na,K-ATPase subunit cannot be determined by comparing the amount of immu-
noreactivity with two different antibodies, nonetheless, differences in the ratio between sam-
ples can be assessed. Here, two identical blots were prepared with samples of canine
sarcolemma as a positive control for the antibodies (C-SL), cerebellar membranes (Cb), and
choroid plexus membranes (CP). The blots were cut in half. The top halves were stained for
Na,K-ATPase  subunit with the pan-specific KETYY antibody, and the bottom halves were
stained with phospholemman antibodies against the C- and N termini, respectively. It can be
seen that, relative to the amount of immunoreactivity for, there was much less phospholem-
man (PLM ) in the cerebellum sample than the choroid plexus sample. Molecular weight mark-
ers are indicated. We have observed that in some gels, phospholemman runs at 15 kDa, as
reported by others, but in these (12% acrylamide Tricine gels), it runs at8 kDa (compared
with Bio-Rad Rainbow molecular weight markers), which is close to its predicted size.
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ther choroid plexus or cerebellum. Figure 6 shows the excellent
yield of solubilization under the conditions used and also shows
controls in which nonimmune IgG was used for a mock precipi-
tation. This control is important to show for immunoprecipita-
tion, because some proteins sediment with the adsorbent, leading
to false-positive signals. Two different Na,K-ATPase -specific
antibodies were used, as well as two different phospholemman
antibodies. Although the two -specific antibodies gave the same
result, the two phospholemman antibodies showed differences
that may be informative about the structure of the Na,K-ATPase–
phospholemman complex.
Figure 6A shows that both anti- antibodies were effective at
coprecipitating phospholemman from bovine choroid plexus
membranes, as was the antibody against the phospholemman C
terminus (PLM-C1, the same antibody used for immunofluores-
cence above). The PLM-B8 antibody against the phospholem-
man N terminus, however, precipitated phospholemman well
but  only weakly. A similar result is seen in Figure 6B, where the
membranes were from bovine cerebellum instead. Despite the
presence of less phospholemman, the  antibodies and the anti-
C-terminal phospholemman antibody coprecipitated  and
phospholemman very well, whereas the anti-N-terminal phos-
pholemman antibody again precipitated phospholemman much
better than . The anti-N-terminal antibody is against the con-
served FXYD domain, and mutagenesis studies with other FXYD
family members have suggested that FXYD is important for in-
teraction with Na,K-ATPase (Beguin et al., 2001). The N termi-
nus of phospholemman in sarcolemma is also very resistant to
proteases, indicating its inaccessibility (Chen et al., 1998). We
propose either that the anti-N-terminal antibody cannot bind to
the extracellular portion of phospholemman when it is tightly
associated with Na,K-ATPase, or that the antibody disrupts the
phospholemman-Na,K-ATPase interaction in detergent. In con-
trast, the C terminus of phospholemman is not constrained in the
same way. Because the C terminus has the phosphorylation sites,
it should be accessible to approach by other proteins, including
antibodies.
To determine which Na,K-ATPase  isoforms interact with
phospholemman, immunoprecipitation from cerebellar mem-
brane fractions was performed using the PLM-C1 antibody (Fig.
7). Each  isoform was detected with a well characterized
isoform-specific monoclonal antibody. The result was that all
three Na,K-ATPase  isoforms coprecipitated. The lack of  in
controls using normal rabbit IgG demonstrates that the precipi-
tation was not an artifact. The conclusion is that phospholem-
man interaction with the Na,K-ATPase is not isoform-specific,
and the implication is that phospholemman is expressed in both
3-containing neurons and 2-containing glia. This conclusion
differs somewhat from that of Crambert et al. (2002), who re-
ported that assembly with 2 was less efficient than with 1 in
oocytes. The discrepancy may be attributable to a lack of2 in the
oocytes, the most abundant partner of 2 in the brain.
Functional interaction of phospholemman with Na,K-ATPase
To test the hypothesis that phospholemman regulates the activity
or properties of the Na,K-ATPase, we incubated purified choroid
plexus Na,K-ATPase (the preparation with the highest propor-
Figure 5. Copurification of phospholemman with Na,K-ATPase. Membranes from bovine
choroid plexus were extracted with SDS and sedimented on a 7–30% sucrose gradient. The
bottom 8 ml were discarded, and 14 2 ml fractions were collected. Fraction samples were
electrophoresed on a Tricine gel, and the blot was cut in half for staining for  (top; K1 anti-
serum) and phospholemman (bottom; PLM-C1). Essentially all of the phospholemman (PLM )
sedimented into the gradient with the Na,K-ATPase. The final specific activity was 200
mol  mg of protein1  hr1 in this experiment. The control lane is a sample of canine
sarcolemma (C-SL).
Figure 6. Coimmunoprecipitation of phospholemman with Na,K-ATPase. Canine sarco-
lemma samples were positive controls for the antibodies (C-SL). As indicated, samples were
precipitated with normal IgG as a negative control,5 or 6H antibodies against Na,K-ATPase
subunit, and anti-phospholemman N- and C-terminal antibodies (PLM-N, PLM-C). Immunopre-
cipitates and their controls were resolved by electrophoresis. Blots were cut in half for staining
for Na,K-ATPase (top; K1,5, or anti-KETYY in different panels) and phospholemman (bot-
tom; PLM-C1). A, Membranes from bovine choroid plexus. B, Membranes from bovine cerebel-
lum. From both tissue sources, anti- antibodies coprecipitated phospholemman (PLM ), but
phospholemman C-terminal antibody coprecipitatedwell, and phospholemman N-terminal
antibody coprecipitated it poorly.
Figure 7. Coimmunoprecipitation of phospholemman with Na,K-ATPase isoforms. Con-
trol lanes include both canine sarcolemma (C-SL) and samples of the bovine cerebellar
membrane-starting material (B-Cb). Immunoprecipitation was performed with normal rabbit
IgG as a negative control and the antibody against the C terminus of phospholemman (PLM-C).
Three identical blots were prepared and cut in half. The bottom halves were all stained with the
phospholemman antibody, but the top halves were stained with isoform-specific anti-Na,K-
ATPase subunit antibodies: antibody 6F for1, McB2 for2, and XVI-F9G10 for3.
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tion of phospholemman) with anti-phospholemman antibodies.
Similar experiments with antibodies to the Na,K-ATPase  sub-
unit gave some of the first evidence for its functional interaction
with the pump (Therien et al., 1997, 1999). PLM-C2 is an anti-
body directed against the C-terminal portion of phospholemman
similar to PLM-C1. Figure 8 shows that PLM-C2, measured at a
range of Na concentrations in vitro, produced a significant de-
crease in activity without affecting the apparent affinity for Na.
Table 1 summarizes additional data. PLM-C2 showed an average
20% reduction of choroid plexus Na,K-ATPase activity measured
in multiple experiments with either 5 or 100 mM NaCl, whereas it
had no effect on kidney Na,K-ATPase, which has the  subunit
instead of phospholemman. There was no inhibition of the
ouabain-insensitive Mg 2-ATPase of either preparation. The
PLM-B8 antibody directed to the N-terminal domain of phos-
pholemman did not have any effect on activity, which may be
attributable to an inability to bind its target if the N-terminal
portion of phospholemman is engaged in interaction with the
Na,K-ATPase. We verified that phospholemman was not phos-
phorylated in the conditions of our experiments (data not
shown).
Discussion
FXYD family members as sodium pump regulators
Phospholemman is the fifth FXYD family member to exhibit
interaction with Na,K-ATPase. There are precedents for the reg-
ulation of other transport ATPases by small membrane-spanning
accessory proteins. Phospholamban, a 52-amino acid protein not
homologous to FXYD proteins, regulates the sarcoplasmic retic-
ulum Ca 2-ATPase (SERCA2a) of the heart. It is phosphorylated
by protein kinase A and mediates -adrenergic stimulation of
contractility by reversing the inhibitory effect it has on the affinity
of SERCA for Ca 2 (Simmerman and Jones, 1998). Its homolog
sarcolipin is expressed in skeletal muscle with a different isoform
of SERCA (Odermatt et al., 1998). Yeast have small membrane
proteins that regulate the plasma membrane ATPase (Navarre et
al., 1994). Ion channels also have accessory proteins that modu-
late functional properties (Suessbrich and Busch, 1999). Thus
regulation of ion transport via small membrane proteins is be-
coming an important theme.
Three lines of evidence presented here support the hypothesis
that phospholemman interacts specifically with the Na,K-
ATPase: the two proteins copurify after SDS-extraction; they
coimmunoprecipitate with antibodies against either component;
and an anti-phospholemman antibody reduces Na,K-ATPase ac-
tivity. Crambert et al. (2002) observed coprecipitation of phos-
pholemman with Na,K-ATPase from cardiac membranes or oo-
cytes, and in oocytes, phospholemman decreased the apparent
affinity for Na (and K). Because we observed inhibition of
activity without effect on Na affinity, at first glance, these results
may seem contradictory. The emerging evidence for functional
effects of FXYD proteins on Na,K-ATPase is quite complex, how-
ever. Effects on ATP hydrolysis, Na affinity, and other proper-
ties appear to be experimentally separable and sometimes subject
to modulation. The bottom line is that FXYD proteins, now in-
cluding phospholemman, can affect functional properties of the
Na,K-ATPase, fine tuning its properties.
The inhibitory effect of antibody suggests that phospholem-
man might be an enzyme activator. In similar experiments on the
 subunit, antibodies against the C terminus reduced activity
(Therien et al., 1997), decreased apparent affinity for ATP (The-
rien et al., 1999), and increased the IC50 for vanadate inhibition
(an experimental test of the distribution between two principal
enzyme conformations, E1 and E2; Pu et al., 2001). Apparent
affinity for ATP was increased in  transfectants of human em-
bryonic kidney 293 and HeLa cells. Most recently, truncation of
the C terminus was shown to abrogate the effect of  on apparent
affinity for ATP (Pu et al., 2002). Together, these and other data
suggested that the anti- antibody favored E2, antagonizing a
normal tendency of  to favor E1.
These apparent activating effects were not the only effects of
the  subunit, however. There were decreases in apparent affinity
for Na, K, or both in enzyme partially purified from trans-
fected mammalian cells (Arystarkhova et al., 1999, 2002; Pu et al.,
2001, 2002) and in oocytes (Beguin et al., 1997, 2001). This
should reduce activity in vivo, because the effects occur in the
physiological range. Anti- antibodies, however, did not inter-
fere with the effect on Na affinity, nor did truncation of the C or
N terminus (Pu et al., 2002). For these reasons, the lack of effect of
anti-phospholemman antibody on Na affinity reported here
does not necessarily contradict the reduction in Na affinity re-
ported in oocytes (Crambert et al., 2002). Modulation of ion
affinity may require the central domain and not the C terminus.
Further complexities in FXYD protein effects are also known.
Figure 8. Effect of PLM-C2 antibody on Na,K-ATPase. Ouabain-sensitive Na,K-ATPase activ-
ity was determined as a function of Na concentration after 4 hr of preincubation at 4°C with
either normal rabbit IgG ( filled circles) or PLM-C2 antibody (open circles). Inset, The following
equation was fitted to the data: v Vmax [Na
]nH/(KNa
nH [Na]nH), where Vmax is the
specific activity at a nonlimiting Na concentration; KNa is the Na
 concentration giving
half-maximal activity; and nH is the Hill coefficient. Best-fitting values for these parameters are
given as mean SEM, average of two experiments performed in duplicate.
Table 1. Anti-phospholemman antibody effects on Na,K-ATPase activity
Tissue
Antibody
PLM-C2 PLM-B8
Na,K-ATPase activity
(% of control) n
Na,K-ATPase activity
(% of control) n
Rat kidney 109 11 4 ND
Choroid plexus 79.2 3.9 13 107.7 7.0 8
Na,K-ATPase purified from rat kidney or bovine choroid plexus was preincubated with the antibodies shown or with
control IgG, and then ouabain-sensitive ATP hydrolytic activity was measured. n, Number of independent determi-
nations; ND, not determined. The specific activities for different choroid plexus Na,K-ATPase preparations used
averaged 15.2 2.0mol  hr1  mg of protein1 (when measured at 5 mM Na) and 37.5mol  hr1  mg
of protein1 (when measured at 100 mM Na). Because no differences between results at 5 or 100 mM Nawere
observed, the data were combined. A paired t test was applied to the results for kidney ( instead of PLM) compared
with choroid plexus. For the antibody PLM-C2, the results were significant at p 0.021 (p 0.05).
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The expression of  N-terminal splice variants, as well as post-
translational modifications, changed how the  subunit altered
Na,K-ATPase affinities for Na and K in NRK-52E cells (Arys-
tarkhova et al., 2002) but not in HeLa cells (Pu et al., 2001). Thus
different domains of  may be responsible for different effects,
and the effects may be modified by factors specific to the cell type.
Interestingly, CHIF (FXYD4) increased the affinity of Na,K-
ATPase for Na (the opposite of the effect of  and phospholem-
man; Beguin et al., 2001; Garty et al., 2002), whereas FXYD7
decreased K affinity at the extracellular site (Beguin et al., 2002).
These proteins are homologous to both  and phospholemman
in the central domain, yet each has a subtly different effect on
Na,K-ATPase properties. There is wide sequence variation in the
extracellular and intracellular domains, providing a further basis
for different functional roles. Because of the complexity of Na,K-
ATPase kinetics, it is going to take considerable effort to fully
understand the properties of these proteins in regulating the so-
dium pump.
Phospholemman also presents the special problem that it has
four potential phosphorylation sites in the cytoplasmic domain,
which are expected to be important in regulating its properties.
The FXYD protein found in shark, PLMS, reduced Na,K-ATPase
activity, and its phosphorylation increased activity (Mahmmoud
et al., 2000). Preliminary experiments on phospholemman phos-
phorylation in vitro produced both stimulatory and inhibitory
effects, suggesting that it matters which sites are phosphorylated
(our unpublished observations).
We have independent evidence that phospholemman may
play a role as an activator of Na,K-ATPase. The specific activity of
Na,K-ATPase in cardiac membranes of a phospholemman
knock-out mouse was significantly lower than in its control (L. G.
Jia, C. Donnet, R. C. Bogaev, R. J. Blatt, C. E. McKinney, K. H.
Day, S. S. Berr, L. R. Jones, J. R. Moorman, K. J. Sweadner, and
A. L. Tucker, unpublished results). This is consistent with the
hypothesis that the PLM-C2 antibody acts as an interfering
antibody that antagonizes a normal stimulatory effect of
phospholemman.
FXYD proteins in the CNS
The association of phospholemman with Na,K-ATPase in
choroid plexus is highly suggestive of a role in the regulation of
CSF secretion. Secretion and Na,K-ATPase activity are both
known to be regulated by hormones and transmitters through
protein kinases (Fisone et al., 1995, 1998; Ellis et al., 2000).
Given that there is uncertainty about the universality of the
Na,K-ATPase protein kinase C site and the accessibility of the
protein kinase A site, phospholemman could be the critical
kinase target.
Phospholemman has a unique distribution in cerebellum.
The stained axons passing through the granular layer were
most likely axons of Purkinje cells, because the cell bodies were
clearly labeled. Similar immunoreactivity has been seen for the
Na,K-ATPase 3 subunit (Peng et al., 1997), which is ex-
pressed in Purkinje neurons (Watts et al., 1991). Although
climbing fibers cannot be ruled out, mossy fibers can be ruled
out, because the glomeruli, which contain their club-like ter-
mini in the granular layer, were unstained. The possibility that
the stained axons could be granule cell axons seems unlikely.
This would require strict subcellular routing to axons and not
somas or dendrites, which were unstained in the granular
layer. Furthermore, the axons extended into the white matter
(data not shown). If Purkinje neurons were the only phos-
pholemman-containing cells, however, coimmunoprecipita-
tion with 2 would not be expected, because that isoform is
expressed mostly in astrocytes and Bergmann glia (Watts et al.,
1991; Peng et al., 1997). Astrocytes in the granular layer did
not stain for phospholemman, but the diffuse immunoreac-
tivity in the molecular layer could be in the plasma membranes
of Bergmann glia as easily as in those of Purkinje neurons,
because the two are closely interdigitated. Immunoreactivities
for Na,K-ATPase isoforms 1–3, 1, and 2 all have a sim-
ilar diffuse distribution in the molecular layer (McGrail et al.,
1991; Cameron et al., 1994; Peng et al., 1997), which reflects
the small size and intimate contact of neuronal and glial pro-
cesses. Phospholemman has been detected in cultures of cer-
ebellar astrocytes from postnatal rats (Moran et al., 2001),
something we have confirmed (data not shown). They pre-
sented evidence that reduction of phospholemman expression
reduced astrocyte volume-sensitive taurine release. However,
Bres et al. (2000) detected phospholemman mRNA in neurons
but not in the astrocytes of the ventral glia limitans of the
supraoptic nucleus and concluded that phospholemman was
not important for volume-sensitive taurine release there.
More investigation is needed.
We can speculate that association with FXYD family mem-
ber accessory proteins is a common theme for Na,K-ATPase
modulation. If so, proteins other than phospholemman must
play this role in other parts of the brain. mRNA for FXYD6,
variously called phosphohippolin (without evidence yet for
phosphorylation), phospholemman-like protein, or vascular
endothelial cell-specific protein (GenBank accession number
AB030908), has been detected by in situ hybridization in cells
of the hippocampal pyramidal cell layer and the granular layer
of the cerebellum (Saito et al., 2001; Yamaguchi et al., 2001).
From Northern blots (Beguin et al., 2002) and the sources of
expressed sequence tags (ESTs; Sweadner and Rael, 2000),
FXYD7 is expressed almost exclusively in the CNS, and ESTs
for FXYD3 (mammary tumor marker 8) and FXYD5 (related
to ion channel) have also been obtained from CNS libraries,
predicting the presence of as many as five FXYD family mem-
bers. Combined with the three Na,K-ATPase  isoforms and
three  isoforms that are expressed in different brain cell types
in different combinations of  and  (McGrail et al., 1991;
Watts et al., 1991; Cameron et al., 1994; Peng et al., 1997;
Martin-Vasallo et al., 2000), the potential subunit diversity of
the sodium pump is considerable. In our opinion, the physi-
ological significance of Na,K-ATPase regulation in the CNS is
much neglected.
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